Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules

scientific article published on 16 October 2007

Impact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1007/S00259-007-0584-1
P698PubMed publication ID17938921

P50authorAbass AlaviQ4663555
P2093author name stringRakesh Kumar
Gonca Bural
Khaled Alkhawaldeh
P2860cites workA PET study of 18FDG uptake in soft tissue massesQ77954110
PET imaging in oncology.Q33992497
Positron emission tomography imaging in evaluation of cancer patientsQ35625706
Clinical applications of PET in oncologyQ35715365
Evaluation and management of solitary and multiple pulmonary nodulesQ36094220
Management of solitary pulmonary nodulesQ37700451
Dual time point 18F-FDG PET imaging for differentiating malignant from inflammatory processesQ40782305
Approach to the solitary pulmonary noduleQ40887493
Dual time point 18F-FDG PET for the evaluation of pulmonary nodules.Q44050019
FDG uptake in breast cancer: correlation with biological and clinical prognostic parameters.Q44149763
Use of a corrected standardized uptake value based on the lesion size on CT permits accurate characterization of lung nodules on FDG-PET.Q44233787
18F-FDG accumulation with PET for differentiation between benign and malignant lesions in the thorax.Q44392799
Determining the likelihood of malignancy in solitary pulmonary nodules with Bayesian analysis. Part I. TheoryQ44893742
The performance of( 18)F-fluorodeoxyglucose positron emission tomography in small solitary pulmonary nodules.Q44919921
Visual and semiquantitative analyses for F-18 fluorodeoxyglucose PET scanning in pulmonary nodules 1 cm to 3 cm in sizeQ45285020
The solitary pulmonary nodule. Ten-year follow-up of veterans administration-armed forces cooperative studyQ45337890
Potential of dual-time-point imaging to improve breast cancer diagnosis with (18)F-FDG PET.Q46790517
Accuracy of PET for diagnosis of solid pulmonary lesions with 18F-FDG uptake below the standardized uptake value of 2.5.Q46972942
Diagnostic efficacy of PET-FDG imaging in solitary pulmonary nodules. Potential role in evaluation and management.Q51652562
Solitary pulmonary nodules: detection of malignancy with PET with 2-[F-18]-fluoro-2-deoxy-D-glucose.Q51653761
Likelihood of malignancy in a solitary pulmonary nodule: comparison of Bayesian analysis and results of FDG-PET scan.Q52258780
110mIn-DTPA-D-Phe1-octreotide for imaging of neuroendocrine tumors with PET.Q53669434
Focal pulmonary abnormalities: evaluation with F-18 fluorodeoxyglucose PET scanning.Q54044710
Controlled prospective study of positron emission tomography using the glucose analogue [18F]fluorodeoxyglucose in the evaluation of pulmonary nodulesQ60607111
Differential diagnosis of lung tumor with positron emission tomography: a prospective studyQ68642006
The solitary pulmonary nodule. Assessment, diagnosis, and managementQ69689459
Survival in males with bronchogenic carcinomas resected as asymptomatic solitary pulmonary nodulesQ70069073
Evaluation and management of solitary and multiple pulmonary nodulesQ70633572
Evaluation of pulmonary lesions with FDG-PET. Comparison of findings in patients with and without a history of prior malignancyQ71089924
The dose uptake ratio as an index of glucose metabolism: useful parameter or oversimplification?Q72096464
Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neckQ73132899
Outcome of solitary pulmonary nodules discovered in an x-ray screening programQ74039754
Prospective investigation of positron emission tomography in lung nodulesQ74329777
Fluorine-18-FDG PET imaging is negative in bronchioloalveolar lung carcinomaQ74650048
Fluorine-18-fluorodeoxyglucose uptake in pneumoniaQ74788063
Assessment of pulmonary lesions with 18F-fluorodeoxyglucose positron imaging using coincidence mode gamma camerasQ77346428
Applications of PET in lung cancerQ77504775
P433issue2
P1104number of pages7
P304page(s)246-252
P577publication date2007-10-16
P1433published inEuropean Journal of Nuclear Medicine and Molecular ImagingQ15708890
P1476titleImpact of dual-time-point (18)F-FDG PET imaging and partial volume correction in the assessment of solitary pulmonary nodules
P478volume35

Reverse relations

cites work (P2860)
Q3382338918F-FDG PET/CT oncologic imaging at extended injection-to-scan acquisition time intervals derived from a single-institution 18F-FDG-directed surgery experience: feasibility and quantification of 18F-FDG accumulation within 18F-FDG-avid lesions and b
Q38253400Accuracy of FDG-PET to diagnose lung cancer in areas with infectious lung disease: a meta-analysis
Q45939044Accuracy of early and delayed FDG PET-CT and of contrast-enhanced CT in the evaluation of lung nodules: a preliminary study on 30 patients.
Q47411672Assessment of factors influencing FDG uptake in non-small cell lung cancer on PET/CT by investigating histological differences in expression of glucose transporters 1 and 3 and tumour size
Q40327142Biphasic ⁶⁸Ga-PSMA-HBED-CC-PET/CT in patients with recurrent and high-risk prostate carcinoma
Q86628849Characterization of solitary pulmonary nodules with 18F-FDG PET/CT relative activity distribution analysis
Q90446746Diagnostic Accuracy of Dual-Time-Point Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomography in Verification Local Recurrence in Pancreatic Cancer Patients
Q40080305Diagnostic classification of solitary pulmonary nodules using dual time 18F-FDG PET/CT image texture features in granuloma-endemic regions.
Q91942629Dual time point [18F]FLT-PET for differentiating proliferating tissues vs non-proliferating tissues
Q42378522Dual time-point 18F-FDG PET/CT imaging with multiple metabolic parameters in the differential diagnosis of malignancy-suspected bone/joint lesions
Q48077703Dual-Time-Point FDG PET/CT to Distinguish Coccidioidal Pulmonary Nodules from Those Due to Malignancy
Q95447056Dynamic changes of FDG uptake and clearance in normal tissues
Q36111424FDG-PET/CT Limited to the Thorax and Upper Abdomen for Staging and Management of Lung Cancer.
Q37441366Imaging of solitary pulmonary nodule-a clinical review
Q38641832Impact of partial-volume correction in oncological PET studies: a systematic review and meta-analysis
Q37590121Kidney stone volume estimation from computerized tomography images using a model based method of correcting for the point spread function
Q37927164Novel molecular imaging in lung and pleural diseases
Q35141896Patlak image estimation from dual time-point list-mode PET data
Q56383742Performance of FDG-PET/CT in solitary pulmonary nodule based on pre-test likelihood of malignancy: results from the ITALIAN retrospective multicenter trial
Q46801464Performance of integrated FDG-PET/CT for differentiating benign and malignant lung lesions--results from a large prospective clinical trial
Q84300165Preoperative predictive model of cervical lymph node metastasis combining fluorine-18 fluorodeoxyglucose positron-emission tomography/computerized tomography findings and clinical factors in patients with oral or oropharyngeal squamous cell carcinom
Q34993919Primary pulmonary amyloidosis misdiagnosed as malignancy on dual-time-point fluoro-deoxyglucose positron emission tomography/computed tomography: A case report and review of the literature
Q92266023Prognostic Significance of Metabolic Parameters and Textural Features on 18F-FDG PET/CT in Invasive Ductal Carcinoma of Breast
Q36303765Promise and pitfalls of quantitative imaging in oncology clinical trials.
Q47760000Respiratory gated PET/CT in a European multicentre retrospective study: added diagnostic value in detection and characterization of lung lesions
Q39448609Respiratory-gated time-of-flight PET/CT during whole-body scan for lung lesions: feasibility in a routine clinical setting and quantitative analysis.
Q36525835The Effects of Preoperative (18)F-FDG PET/CT in Breast Cancer Patients in Comparison to the Conventional Imaging Study.
Q42905058Utility of TL‐201 SPECT in clarifying false‐positive FDG‐PET findings due to osteoradionecrosis in head and neck cancer
Q42864238What is the role of FDG-PET in thoracic oncology in 2010?
Q38077707When should we recommend use of dual time-point and delayed time-point imaging techniques in FDG PET?
Q88610903Zero-Extra-Dose PET Delayed Imaging with Data-Driven Attenuation Correction Estimation
Q87753246[Combined use of thin-section CT and 18F-FDG PET/CT for characterization of solitary pulmonary nodules]
Q82332348[PET-CT for evaluation of the solitary pulmonary nodule: an update]

Search more.